Management of gastrointestinal motility disorders. A practical guide to drug selection and appropriate ancillary measures
- PMID: 8891462
- DOI: 10.2165/00003495-199652040-00003
Management of gastrointestinal motility disorders. A practical guide to drug selection and appropriate ancillary measures
Abstract
The focus of management of gastrointestinal motility disorders should be to improve survival and quality of life. Some motor disorders are annoying, but are compatible with virtually normal activity and carry no significant life risk. Conversely, other motor disorders are highly incapacitating and may shorten life expectancy because of complications and nutritional impairment. Management is based first on establishing the correct diagnosis and prognosis; secondly, on adjusting therapy to the severity of illness; and thirdly, on preventing significant complications. Simple recommendations on appropriate changes in lifestyle and reassurance may suffice in mild cases. Pharmacological therapy and, exceptionally, surgical or nutritional measures may be required in other patients. Generally, pharmacological agents should be directed towards correcting specific pathophysiological abnormalities, but this is not always possible. Symptomatic relief may be achieved on an empirical basis. Long term treatment may often require the combination of different therapeutic approaches either sequentially or simultaneously.
Similar articles
-
Clinical management of motility disorders in children.Semin Pediatr Surg. 2009 Nov;18(4):224-38. doi: 10.1053/j.sempedsurg.2009.07.004. Semin Pediatr Surg. 2009. PMID: 19782304 Review.
-
Cisapride therapy for gastrointestinal disease.J Pediatr Gastroenterol Nutr. 1996 Apr;22(3):259-69. doi: 10.1097/00005176-199604000-00007. J Pediatr Gastroenterol Nutr. 1996. PMID: 8708879 Review. No abstract available.
-
[Prokinetics and diabetes mellitus].Vnitr Lek. 2004 May;50(5):358, 360-2. Vnitr Lek. 2004. PMID: 15305632 Review. Czech.
-
Appraisal of medium- and long-term treatment of gastroparesis and chronic intestinal dysmotility.Am J Gastroenterol. 1994 Oct;89(10):1769-74. Am J Gastroenterol. 1994. PMID: 7942664 Review.
-
Prokinetics in the treatment of acute intestinal pseudo-obstruction.IDrugs. 2004 Feb;7(2):160-5. IDrugs. 2004. PMID: 15057661 Review.
Cited by
-
Xiangshaliujunzi Decoction for the treatment of diabetic gastroparesis: a systematic review.World J Gastroenterol. 2014 Jan 14;20(2):561-8. doi: 10.3748/wjg.v20.i2.561. World J Gastroenterol. 2014. PMID: 24574726 Free PMC article.
-
Curcumin improves expression of SCF/c-kit through attenuating oxidative stress and NF-κB activation in gastric tissues of diabetic gastroparesis rats.Diabetol Metab Syndr. 2013 Mar 1;5(1):12. doi: 10.1186/1758-5996-5-12. Diabetol Metab Syndr. 2013. PMID: 23448582 Free PMC article.
-
Current concepts on pathophysiology, diagnosis and treatment of diffuse oesophageal spasm.Drugs. 2001;61(5):579-91. doi: 10.2165/00003495-200161050-00004. Drugs. 2001. PMID: 11368284 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources